Management of Hypertriglyceridemia in the Diabetic Patient
Open Access
- 8 June 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Diabetes Reports
- Vol. 10 (4), 316-320
- https://doi.org/10.1007/s11892-010-0124-4
Abstract
The hypertriglyceridemia of diabetes can be classified into mild to moderate (triglycerides between 150–499 mg/dL) and severe hypertriglyceridemia (triglycerides ≥500 mg/dL). As in any other individuals with hypertriglyceridemia, secondary causes need to be excluded. The management of severe hypertriglyceridemia (chylomicronemia syndrome) includes aggressive reduction of triglycerides with intravenous insulin, fibrates, omega-3 fatty acids, and/or niacin therapy to avert the risk of pancreatitis. In patients with mild to moderate hypertriglyceridemia, the treatment of choice is statin therapy to achieve the low-density lipoprotein (LDL) and non-high-density lipoprotein (HDL) target goals. The evidence base would favor niacin therapy in combination with statin therapy to achieve the goals pertaining to LDL cholesterol and non-HDL cholesterol. The data about the combination of fibrate therapy with statin therapy are disappointing.Keywords
This publication has 27 references indexed in Scilit:
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Extended-Release Niacin or Ezetimibe and Carotid Intima–Media ThicknessNew England Journal of Medicine, 2009
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic SyndromeDiabetes Care, 2009
- Therapy and clinical trials: management of diabetic dyslipidemiaCurrent Opinion in Lipidology, 2009
- Investigation and management of hypertriglyceridaemiaJournal of Clinical Pathology, 2008
- Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studiesThe Lancet, 2008
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisThe Lancet, 2008
- HypertriglyceridemiaNew England Journal of Medicine, 2007
- Prescription omega-3 fatty acids for the treatment of hypertriglyceridemiaAmerican Journal of Health-System Pharmacy, 2007
- U.K. Prospective Diabetes Study 27: Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sexDiabetes Care, 1997